US Stock MarketDetailed Quotes
KTRA Kintara Therapeutics
- 0.2299
- +0.0029+1.28%
Close Oct 16 16:00 ET
- 0.2287
- -0.0012-0.52%
Post 19:59 ET
12.80MMarket Cap-718P/E (TTM)
0.2384High0.1902Low6.01MVolume0.2351Open0.2270Pre Close1.33MTurnover10.80%Turnover RatioLossP/E (Static)55.66MShares4.480052wk High-1.96P/B12.78MFloat Cap0.081052wk Low--Dividend TTM55.59MShs Float6800.0000Historical High--Div YieldTTM21.23%Amplitude0.0810Historical Low0.2220Avg Price1Lot Size
About Kintara Therapeutics Company
Kintara Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of new cancer therapies. Its product pipeline includes VAL-083 and REM-001. The company was founded by Jeffrey A. Bacha, Dennis M. Brown, and William J. Garner on June 24, 2009 and is headquartered in San Diego, CA.
Company Profile
SymbolKTRA
Company NameKintara Therapeutics
Listing DateJul 12, 2016
Founded2009
CEOMr. Robert E. Hoffman, C.P.A.
MarketNASDAQ
Employees10
Fiscal Year Ends06-30
Address9920 Pacific Heights Boulevard,Suite 150
CitySan Diego
ProvinceCalifornia
CountryUnited States of America
Zip Code92121
Phone1-858-350-4364
Websitehttp://www.kintara.com
Company Executives
- Name
- Position
- Salary
- Robert E. Hoffman, C.P.A.
- Chairman of the Board, President, Principal Accounting Officer, Chief Executive Officer and Interim Chief Financial Officer
- 1.18M
- Robert J. Toth, Jr
- Independent Director
- 80.94K
- Laura Johnson
- Independent Director
- 79.94K
- Tamara A. Favorito
- Independent Director
- 83.44K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
